Proactive treatment with 0.03% tacrolimus cream in children with moderate/severe dermatitis - Trial 2015-001040-11

Name: Clinical Trial 2015-001040-11
Creator: Astellas Pharma China, Inc.
Keywords: Atopic Dermatitis, clinical trial

Access comprehensive clinical trial information for 2015-001040-11 through Pure Global AI's free database. This phase not specified trial is sponsored by Astellas Pharma China, Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-001040-11

Trial Details

EU Clinical Trials Register • 2015-001040-11

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Proactive treatment with 0.03% tacrolimus cream in children with moderate/severe dermatitis

Study Focus

Disease/Condition

Atopic Dermatitis

Sponsor & Location

Primary Sponsor

Astellas Pharma China, Inc.

Funder

Astellas Pharma China, Inc

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

Patients with known allergy to tacrolimus ointment;

ICD-10 Classifications

Atopic dermatitis

Atopic dermatitis, unspecified

Other atopic dermatitis

Acute atopic conjunctivitis

Allergic contact dermatitis

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-001040-11

Type

Non-Device Trial